![It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn](https://cdn.mdedge.com/files/s3fs-public/obgm03210-pearlman_web_t1.jpg)
It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn
![PDF) An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation PDF) An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation](https://i1.rgstatic.net/publication/317157626_An_updated_PREDICT_breast_cancer_prognostication_and_treatment_benefit_prediction_model_with_independent_validation/links/59728b0b0f7e9b401694486e/largepreview.png)
PDF) An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
![Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/d9703228-fc3a-4361-8574-cece79e56c05/gr1.jpg)
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology
![Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda](https://integrativeoncology-essentials.com/wp-content/uploads/2019/03/Screen-Shot-2019-03-28-at-11.39.28-AM-519x1024.png)
Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda
![Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-021-00296-8/MediaObjects/41523_2021_296_Fig1_HTML.png)
Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer
![An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom | British Journal of Cancer An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.bjc.6605283/MediaObjects/41416_2009_Article_BF6605283_Fig2_HTML.jpg)
An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom | British Journal of Cancer
![Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00288-8/MediaObjects/41523_2021_288_Fig1_HTML.png)
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer
![Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095980491730833X-gr2.jpg)
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect
![Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator | SpringerLink Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-021-06113-x/MediaObjects/10549_2021_6113_Fig5_HTML.png)
Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator | SpringerLink
![Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients - ScienceDirect Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804912000986-gr2.jpg)
Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients - ScienceDirect
![JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report](https://www.mdpi.com/jpm/jpm-02-00071/article_deploy/html/images/jpm-02-00071-g001.png)